亿帆医药 (002019)
YIFAN PHARMACEUTICAL CO.,LTD
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 121639.01
- Circulating A-Shares(W): 84147.41
- Earnings Per Share(RMB): 0.3200
- Net Assets Per Share(RMB): 7.2601
- Operating Revenue(W RMB): 392270.94
- Total Profit(W RMB): 43481.10
- Net Profit Attributable to Parent(W RMB): 38778.67
- Net Profit Growth Rate(%): 5.84
- Weighted Return on Equity(%): 4.4400
- Operating Cash Flow Per Share(RMB): 0.2680
- Undistributed Profit Per Share(RMB): 3.8923
- Capital Reserve Per Share(RMB): 2.3407
2. Main Business
The main business covers:
- R&D, production, sales and promotion services of pharmaceutical products
- R&D, production and sales of active pharmaceutical ingredients (APIs)
- R&D, production and sales of polymer materials
3. Company Basic Information
- Company Name: Yifan Pharmaceutical Co., Ltd.
- Listing Date: 2004-07-13
- Industry: Pharmaceutical Manufacturing
- Address: No. 50 Qinshan, Jincheng Street, Lin'an District, Hangzhou City, Zhejiang Province
- Website: www.yifanyy.com
- Company Profile: The company is an innovative pharmaceutical R&D and manufacturing enterprise, equipped with a national post-doctoral research station and a provincial enterprise technology center (R&D center). It owns several high-tech enterprises. Guided by professional, specialized, and therapeutic pharmaceutical product lines, the company continuously innovates and develops in key areas such as macromolecular biologics, high-end chemical drugs, and specialty traditional Chinese medicines. Its pharmaceutical business covers all provinces and cities in mainland China, with its drug preparations reaching over 60% of hospitals above the secondary level nationwide. It is also the world's largest producer and supplier of Vitamin B5 and Provitamin B5, with products sold worldwide.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 2735.92 | 3.25 |
| 2 | Shanghai Yingshui Investment Management Co., Ltd. - Yingshui Qianlong No.13 Private Securities Investment Fund | Private Securities Investment Fund | 823.00 | 0.98 |
| 3 | Shanghai Yingshui Investment Management Co., Ltd. - Yingshui Hexie No.7 Private Securities Investment Fund | Private Securities Investment Fund | 822.00 | 0.98 |
| 4 | Shanghai Yingshui Investment Management Co., Ltd. - Yingshui Xunyang No.4 Private Securities Investment Fund | Private Securities Investment Fund | 822.00 | 0.98 |
| 5 | Anhui Zhong'an Health Investment Management Co., Ltd. - Anhui Province Zhong'an Health and Elderly Care Service Industry Investment Partnership (Limited Partnership) | General Legal Person | 730.00 | 0.87 |
| 6 | Jinyuan Shun'an Gem Dynamic Mixed Securities Investment Fund | Fund | 11.20 | 0.01 |
5. Concept Sectors
- Vitamin
- Generic Drugs
- Degradable Plastics
- Medical Aesthetics Concept
- New Materials
- Hepatitis Concept
- Innovative Drugs
- Synthetic Biology
- Margin Trading & Securities Lending
- MSCI Mid Cap
- Heavily Held by Private Funds
- SME 300 Index
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information